Back to Search
WESLEY BLAIR, MD
MD
Internal Medicine Physician
NPI: 1538653506IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
2018020246(MO)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
MEHARRY MEDICAL COLLEGE SCHOOL OF MEDICINE
Class of 2018
Research & Publications (20)
Inhibitors of HIV-1 attachment. Part 4: A study of the effect of piperazine substitution patterns on antiviral potency in the context of indole-based derivatives.
PMID 19664921·Bioorg Med Chem Lett·2009
8-other
Inhibitors of HIV-1 attachment. Part 3: A preliminary survey of the effect of structural variation of the benzamide moiety on antiviral activity.
PMID 19632112·Bioorg Med Chem Lett·2009
8-other
Inhibitors of HIV-1 attachment. Part 2: An initial survey of indole substitution patterns.
PMID 19251416·Bioorg Med Chem Lett·2009
7-preclinical
Identification and characterization of UK-201844, a novel inhibitor that interferes with human immunodeficiency virus type 1 gp160 processing.
PMID 17646410·Antimicrob Agents Chemother·2007
8-other
Effects of parental PTSD on the cortisol response to dexamethasone administration in their adult offspring.
PMID 17202561·Am J Psychiatry·2007
4-observational
Implied preemption of state tort law claims against prescription drug manufacturers based upon FDA approval.
PMID 16959653·J Leg Med·2006
8-other
Are adult offspring reliable informants about parental PTSD? A validation study.
PMID 16891603·Ann N Y Acad Sci·2006
8-other
Longitudinal assessment of dissociation in Holocaust survivors with and without PTSD and nonexposed aged Jewish adults.
PMID 16891598·Ann N Y Acad Sci·2006
8-other
A novel HIV-1 antiviral high throughput screening approach for the discovery of HIV-1 inhibitors.
PMID 15708637·Antiviral Res·2005
7-preclinical
High-throughput human immunodeficiency virus type 1 (HIV-1) full replication assay that includes HIV-1 Vif as an antiviral target.
PMID 16127060·Antimicrob Agents Chemother·2005
8-other
Cell-based and biochemical screening approaches for the discovery of novel HIV-1 inhibitors.
PMID 16112209·Antiviral Res·2005
6-review
Investigations of electrospray sample deposition for polymer MALDI mass spectrometry.
PMID 14766284·J Am Soc Mass Spectrom·2004
8-other
5th Antiviral Drug Discovery and Development Summit.
PMID 15268642·Expert Opin Investig Drugs·2004
7-preclinical
Discovery of 4-benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): a novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions.
PMID 13678401·J Med Chem·2003
7-preclinical
A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding.
PMID 12930892·Proc Natl Acad Sci U S A·2003
7-preclinical
Tri-alpha-naphthylbenzene as a crystalline or glassy matrix for matrix-assisted laser desorption/ionization: a model system for the study of effects of dispersion of polymer samples at a molecular level.
PMID 12112271·Rapid Commun Mass Spectrom·2002
8-other
BMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agents.
PMID 10898681·Antimicrob Agents Chemother·2000
8-other
Post-source decay in the analysis of polystyrene by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
PMID 11118117·J Am Soc Mass Spectrom·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 BARNES JEWISH HOSPITAL PLZ
SAINT LOUIS, MO 63110 - Phone
- (314) 362-5000
Quick Facts
- NPI
- 1538653506
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 8
- Publications
- 20
Are you this provider?
Claim Your Profile